Replicative Senescence
Replicative Senescence - Related Videos
02:15
Replicative Cell Senescence
0 Views •
2023
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:15
Replicative Cell Senescence
0 Views •
2021
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
06:51
Techniques to Induce and Quantify Cellular Senescence
0 Views •
Cited by 180 •
2017
Cellular senescence, the irreversible state of cell-cycle arrest, can be induced by various cellular stresses. Here, we describe protocols to induce cellular senescence and methods to assess markers of senescence.
09:18
A Sensitive Method to Quantify Senescent Cancer Cells
0 Views •
Cited by 39 •
2013
Whether senescence prevents or promotes tumorigenesis remains controversial. Since chemotherapeutical drugs can induce cancer cells to senesce, studying senescence is essential for proposing new therapies. However, the standard and broadly used β-galactosidase assay presents major drawbacks. We propose here a rapid and sensitive flow cytometry-based assay to quantify senescence.
02:31
Chromosome Replication
0 Views •
2020
Before a cell can divide, it must accurately replicate all of its chromosomes, including the DNA and its associated histone and non-histone proteins. This process begins at numerous origins of replication during the S phase of the cell cycle in each of a cell’s chromosomes simultaneously. Certain nucleotides can act as origins of replication, but these sequences are not well defined - especially in complex, multi-cellular, eukaryotic species. The length of DNA that spans an origin of...
FAQs
During repeated DNA replication, telomeres progressively shorten. Once this shortening is sufficient to signal a DNA damage response, the cell activates checkpoint pathways that prevent further cell-cycle progression. This mechanism links proliferative history to division limits and helps explain why continued replication can produce a stable arrest rather than unrestricted growth.
The p53–p21 and p16–RB pathways act as complementary cell-cycle enforcement systems. Signals associated with telomere damage can activate these pathways, which impose and maintain the division arrest. Their involvement is important because it connects the initiating damage response with the long-term stability of the senescent state.
A halt in proliferation does not mean that the cell becomes inactive. Senescent cells remain metabolically active and can release inflammatory and tissue-remodeling factors through the senescence-associated secretory phenotype, or SASP. This activity allows them to influence neighboring cells and tissue environments, making senescence relevant beyond the arrested cell itself.
A useful investigation considers several linked features rather than cell-cycle arrest alone: progressive telomere shortening, activation of the DNA damage response, engagement of p53–p21 or p16–RB signaling, continued metabolic activity, and SASP production. Examining these features together helps distinguish the broader senescent state from a simple temporary pause in proliferation.
Because repeated proliferation can lead to stable arrest and altered signaling, Replicative Senescence provides a framework for studying age-related decline and tissue maintenance. Senescent cells may affect their surroundings through inflammatory and tissue-remodeling factors, so their accumulation or activity can be considered in relation to changes in tissue function over time.
The process has a dual research relevance in cancer biology and therapy development. Cell-cycle arrest provides a tumor-suppressive barrier to continued proliferation, while the SASP can modify the surrounding tissue environment. These contrasting effects help motivate research on senolytic therapies, which aim to address senescent-cell populations in age- or disease-related contexts.